Stay updated on Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial
Sign up to get notified when there's something new on the Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial page.

Latest updates to the Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.5.3 to v3.5.4, representing a small metadata/quality-control update to the page.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s interface/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a technical release rather than a change to the clinical trial record.SummaryDifference0.0%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No trial details or eligibility criteria appear to be changed.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3; no visible changes to the study details page.SummaryDifference0.0%

- Check80 days agoChange DetectedAdded new timeline details: last update on 2026-02-18; primary completion and study completion expected in 2027-03; enrollment reported as 130. Removed several historical status entries for sponsor/location details.SummaryDifference0.5%

Stay in the know with updates to Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab vs Cyclophosphamide in Severe MMP Clinical Trial page.